AccessPak for HIV PEP Expanded with Kaletra and Ixekizumab Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Ixekizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ixekizumab
Brand name: Taltz Autoinjector, Taltz Prefilled Syringe
Synonyms: Ixekizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Ixempra
- AccessPak for HIV PEP Expanded with Kaletra-Ixempra Kit
- AccessPak for HIV PEP Expanded with Kaletra-Ixiaro
- AccessPak for HIV PEP Expanded with Kaletra-Ixifi Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Ixinity
- AccessPak for HIV PEP Expanded with Kaletra-Ixinity Intravenous
- Ixekizumab Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Ixekizumab Subcutaneous-Accolate
- Ixekizumab Subcutaneous-Accretropin
- Ixekizumab Subcutaneous-Accucaine
- Ixekizumab Subcutaneous-AccuHist Drops
- Ixekizumab Subcutaneous-AccuHist PDX Drops